Healio OSN

March 22, 2023

Enrollment complete in Visus phase 3 trial of combination drug therapy for presbyopia

Key takeaways:

• Visus Therapeutics completed enrollment in the BRIO-I trial, which is investigating the safety and efficacy of Brimochol PF for presbyopia treatment.
• Results from the trial are expected later this year.

READ MORE